TEDCO, Maryland’s economic engine for technology companies, announced today its Seed Fund invested $200K in a technology start-up based in Maryland. TEDCO’s Seed Fund invests in early-stage, technology and life sciences companies and includes gap financing.
A global pandemic, rising racial tensions and a greatly anticipated (and hotly contested) presidential election: 2020 was a year like no other in recent memory.
The Columbia-based Maryland Technology Development Corp.’s (TEDCO) new economic relief initiative to benefit socially and economically disadvantaged and rural early-stage technology-based businesses hit hardest by the COVID-19 pandemic is now available.
As the Director of Federal Programs, Kim is responsible for engaging with the federal government to convert scientific research into new jobs and new businesses.
Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced it submitted an Investigational New Drug (IND) application with the U.S.
Maryland Technology Development Corp. (TEDCO) will distribute $5 million to local startups that have been hit especially hard by the Covid-19 pandemic, namely rural businesses or those led by socially and economically disadvantaged founders.
The agency is administering a state relief fund for entrepreneurs who are disadvantaged, or based in rural areas. Expect the funds to be available in February 2021.
